Table 1 The clinical data of the 40 patients included in the analysis
Clinical characteristics | Value |
|---|---|
Age, years | |
Median (range) | 45 (22–65) |
Sex, no. (%) | |
Male | 22 (55) |
Female | 18 (45) |
Prior systemic chemotherapies, no. (%) | |
1 | 5 (12.5) |
2 | 12 (30) |
3 | 8 (20) |
≥ 4 | 15 (37.5) |
Tumor site/type, no. (%) | |
Head and neck | 14 (35) |
Neuroendocrine neoplasm G3 | 4 |
Squamous cell carcinoma | 3 |
Adenoid cystic carcinoma | 3 |
Adenocarcinoma | 2 |
Chondrosarcoma | 1 |
Carcinosarcoma | 1 |
Gastrointestinal | 12 (30) |
Neuroendocrine neoplasm G3 | 6 |
Neuroendocrine MANEC | 2 |
Neuroendocrine neoplasm G2 | 1 |
GIST | 1 |
Mesothelioma | 1 |
Squamous cell carcinoma | 1 |
Urogenital | 8 (20) |
Neuroendocrine neoplasm G3 | 2 |
Germ cell tumor | 2 |
Leiomyosarcoma | 1 |
Pheochromocytoma | 1 |
Teratoma | 1 |
Squamous cell carcinoma | 1 |
Lung | 3 (7.5) |
Adenocarcinoma | 2 |
Neuroendocrine neoplasm G2 | 1 |
Cancer of unknown primary | 3 (7.5) |
Adenocarcinoma | 1 |
Neuroendocrine neoplasm G3 | 1 |
DSRCT | 1 |